|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.00 USD | -3.22% |
|
-5.92% | -0.67% |
| 07-09 | Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus | MT |
| 07-09 | Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.22% | -5.92% | -1.52% | -4.32% | -0.67% | +93.03% | +262.15% | +269.93% | -42.16% | 37.3B | |
| -2.73% | -3.51% | +4.40% | +23.72% | +6.72% | +48.62% | +152.87% | +389.84% | +1,334.16% | 1,051B | |
| -1.67% | -3.18% | +8.95% | +6.25% | +20.23% | +52.00% | +56.75% | +49.10% | +98.66% | 609B | |
| -0.44% | +2.14% | +17.04% | +21.60% | +10.89% | +33.88% | +84.04% | +119.53% | +300.16% | 450B | |
| -0.75% | -1.46% | +3.72% | +3.66% | +1.07% | +28.32% | +22.33% | -7.07% | +32.42% | 330B | |
| -1.52% | -0.95% | +4.06% | +3.60% | +12.32% | +33.38% | +38.39% | +48.17% | +53.40% | 284B | |
| -1.70% | -3.54% | -6.45% | -18.11% | -10.22% | +20.26% | +17.88% | +49.03% | +173.08% | 263B | |
| -0.58% | +1.78% | +11.96% | +25.96% | +0.85% | -20.89% | -38.37% | +17.94% | +76.91% | 223B | |
| -0.58% | +0.21% | +7.87% | +2.50% | +11.26% | +23.55% | +56.94% | +47.60% | +124.12% | 198B | |
| -0.80% | +2.60% | +7.64% | -3.22% | +8.53% | +23.09% | +68.71% | +95.24% | +55.91% | 167B | |
| -1.20% | +2.40% | -1.82% | -10.20% | -0.60% | +1.14% | -32.08% | -38.36% | -32.45% | 143B | |
| -0.95% | +4.48% | +11.41% | -0.02% | +11.53% | +27.03% | -3.06% | -9.34% | -20.29% | 124B | |
| -1.06% | -1.01% | +6.39% | +8.91% | +5.99% | +4.50% | +34.00% | +141.17% | +449.58% | 123B | |
| -0.56% | +0.89% | +3.74% | -6.23% | -7.02% | -7.47% | -19.83% | -11.36% | +2.89% | 106B | |
| -1.80% | -4.05% | -2.26% | -12.22% | +3.15% | +39.61% | +38.34% | +6.48% | -9.00% | 103B | |
| +1.16% | -0.87% | -2.98% | -12.26% | -11.14% | +4.58% | +84.83% | +76.55% | +473.76% | 74.25B | |
| -2.37% | -5.61% | +25.03% | +15.11% | +27.83% | +70.98% | -7.89% | -4.22% | -48.45% | 54.48B | |
| +2.53% | +2.26% | +11.07% | -1.90% | +13.34% | +26.24% | +26.50% | +46.56% | +22.76% | 53.32B | |
| +4.47% | -0.32% | +14.77% | -1.35% | -6.71% | -5.43% | +19.02% | -8.84% | +250.98% | 51.73B | |
| -0.62% | +2.54% | +11.08% | +3.46% | -1.01% | +3.43% | +13.28% | - | - | 44.24B | |
| Average | -0.55% | +0.65% | +6.70% | +2.25% | +4.82% | +24.99% | +43.74% | +67.26% | +173.50% | 224.47B | |
| Weighted average by Cap. | -1.00% | +0.27% | +6.45% | +8.72% | +7.11% | +31.70% | +64.57% | +129.32% | +407.88% |
- Stock Market
- Stocks
- TEVA Stock
- Sector Teva Pharmaceutical Industries Limited
Select your edition
All financial news and data tailored to specific country editions
